Allarity Therapeutics (ALLR) Deferred Taxes (2020 - 2024)
Allarity Therapeutics' (ALLR) quarterly Deferred Taxes came in at -$432000.0 in Q3 2024, down 2985.71% on a QoQ basis from -$14000.0 in Q1 2024.
Allarity Therapeutics (ALLR) Deferred Taxes (2020 - 2024) Analysis & Trends
Allarity Therapeutics (ALLR) has 5 years of Deferred Taxes data on file, last reported at -$432000.0 in Q3 2024.
- Quarterly Deferred Taxes changed N/A year-over-year to -$432000.0 in Q3 2024, while the trailing twelve-month figure through Jun 2025 was -$432000.0 (down 131.02% YoY) and the FY2024 annual result came in at -$446000.0, down 559.79% from the prior year.
- Deferred Taxes declined to -$432000.0 in Q3 2024, from -$14000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $168000.0 in Q3 2021 to a low of -$1.2 million in Q1 2022.
- A 5-year average of -$163250.0 and a median of -$36500.0 in 2020 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2022 — Deferred Taxes sank 3818.18% — and 2023, when it jumped 135.93%.
- Tracing ALLR's Deferred Taxes over 5 years: stood at -$18000.0 in 2020, then plunged by 600.0% to -$126000.0 in 2021, then slumped by 114.29% to -$270000.0 in 2022, then jumped by 135.93% to $97000.0 in 2023, then tumbled by 545.36% to -$432000.0 in 2024.
- The last three Deferred Taxes figures came in at -$432000.0 (Q3 2024), -$14000.0 (Q1 2024), and $97000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -432,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | 97,000.00 |
| Dec 31, 2022 | -270,000.00 |
| Sep 30, 2022 | -119,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | -1.23 Mn |
| Dec 31, 2021 | -126,000.00 |
| Sep 30, 2021 | 168,000.00 |
| Jun 30, 2021 | -55,000.00 |
| Mar 31, 2021 | 33,000.00 |
| Dec 31, 2020 | -18,000.00 |